![Catherine Hu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Catherine Hu worked as a Director of Investor Relations at Alexion Pharmaceuticals, Inc. She then worked as an Executive Director of Investor Relations and Corporate Communications at Scholar Rock Holding Corp.
from 2018 to 2021.
Ms. Hu received an undergraduate degree from The Leonard N Stern School of Business.
| Companies | Position | End |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Investor Relations Contact | 01/10/2021 |
| ALEXION PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 3 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
